Sponsor:
Wayne State University
Code:
NCT05003765
Conditions
Post-operative Pain Management
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Bupivacaine 0.25% Injectable Solution
Bupivacaine 0.25% Injectable Solution, Magnesium Sulfate 200 mg
Bupivacaine 0.25% Injectable Solution, Magnesium Sulfate 200 mg, Buprenorphine 300 mcg
Brief summary:
Conditions
Post-operative Pain Management
Study ID
NCT05003765
Start date
Aug 6, 2020
Status verified date
Aug, 2021
Completion date
May 1, 2022
Anticipated
Primary completion date
May 1, 2022
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Enrollment
200 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Supportive Care
Arms
no intervention: Saline injection (CTRL)
experimental: SPIP Block
experimental: SPIP Block + Magnesium
experimental: SPIP Block + Magnesium + Buprenorphine
Interventions
Bupivacaine 0.25% Injectable Solution
Bupivacaine 0.25% Injectable Solution, Magnesium Sulfate 200 mg
Bupivacaine 0.25% Injectable Solution, Magnesium Sulfate 200 mg, Buprenorphine 300 mcg
Primary outcome measure
Central contacts
Locations
St. Joseph Mercy Oakland Hospital
Recruiting
Pontiac, Michigan, United States, 48341
Contacts
Sponsor
Wayne State University
Last update posted
Aug 12, 2021
Last verified
Aug, 2021
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Wayne State University on 2021-08-12.